117 related articles for article (PubMed ID: 6339786)
1. Intraperitoneal (125I) insulin absorption during intermittent and continuous peritoneal dialysis.
Wideröe TE; Smeby LC; Berg KJ; Jörstad S; Svartås TM
Kidney Int; 1983 Jan; 23(1):22-8. PubMed ID: 6339786
[No Abstract] [Full Text] [Related]
2. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration.
Quellhorst E
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S92-6. PubMed ID: 11792768
[TBL] [Abstract][Full Text] [Related]
3. Estimate the insulin absorption in diabetic patients on peritoneal dialysis.
Pantsulaia T; Chokhonelidze I; Lomitashvili T
Georgian Med News; 2006 Nov; (140):28-30. PubMed ID: 17179582
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal insulin for control of glucose level in insulin dependent diabetic patients treated by CAPD.
Rottembourg J; Balducci A; Baumelou A; Jacq D; Agrafiotis A; Slama G
Proc Clin Dial Transplant Forum; 1980; 10():305-7. PubMed ID: 7050993
[No Abstract] [Full Text] [Related]
5. Peritoneal dialysis in diabetics. Optimal insulin therapy on CAPD: intraperitoneal versus subcutaneous treatment.
Scarpioni L; Ballocchi S; Scarpioni R; Cristinelli L
Perit Dial Int; 1996; 16 Suppl 1():S275-8. PubMed ID: 8728206
[No Abstract] [Full Text] [Related]
6. Intraperitoneal insulin: new alternative for diabetic CAPD patients.
Bandel-Walcer R; Myers C; Malgaonkar S; Lyman N
AANNT J; 1982 Aug; 9(4):31-5. PubMed ID: 7049191
[No Abstract] [Full Text] [Related]
7. Advisability of switching of i.p. insulin in to CAPD.
Quellhorst E
Semin Dial; 2002; 15(5):376. PubMed ID: 12358646
[No Abstract] [Full Text] [Related]
8. Transfer of native insulin through the peritoneal membrane during CAPD in non-diabetic and diabetic patients.
Ersoy FF; Karayalcin U; Karayalcin B; Sapan M; Bozcuk H; Süleymanlar G; Yakupoglu G
Adv Perit Dial; 1995; 11():119-22. PubMed ID: 8534683
[TBL] [Abstract][Full Text] [Related]
9. Insulin therapy in uremic diabetic patients on continuous ambulatory peritoneal dialysis; comparison of intraperitoneal and subcutaneous administration.
Scarpioni L; Ballocchi S; Castelli A; Scarpioni R
Perit Dial Int; 1994; 14(2):127-31. PubMed ID: 8043664
[TBL] [Abstract][Full Text] [Related]
10. Continuous ambulatory peritoneal dialysis in insulin-dependent diabetic patients: a 40-month experience.
Rottembourg J; el Shahat Y; Agrafiotis A; Thuillier Y; de Groc F; Jacobs C; Legrain M
Kidney Int; 1983 Jan; 23(1):40-5. PubMed ID: 6339788
[No Abstract] [Full Text] [Related]
11. [Intraperitoneal insulin in continuous ambulatory peritoneal dialysis].
Riambau E; Aubia J; Llorach I; Lloveras J; Masramón J; Orfila A; Llorach M
Rev Clin Esp; 1982 Mar; 164(5):333-4. PubMed ID: 7048442
[No Abstract] [Full Text] [Related]
12. Three diabetic peritoneal dialysis patients receiving intraperitoneal insulin with dosage adjustment based on capillary glucose levels during peritoneal equilibrium tests.
Thorp ML; Wilks TS
Am J Kidney Dis; 2004 May; 43(5):927-9. PubMed ID: 15112185
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal insulin in the diabetic continuous ambulatory peritoneal dialysis (CAPD) patient - nursing management.
Adair CM
AANNT J; 1982 Apr; 9(2):62-3. PubMed ID: 7039632
[No Abstract] [Full Text] [Related]
14. [Peritoneal dialysis for diabetic nephropathy: a case of intraperitoneal insulin administration].
Abe T; Kusumi H; Kanazawa M
Hinyokika Kiyo; 1972 Mar; 18(3):133-6. PubMed ID: 5065298
[No Abstract] [Full Text] [Related]
15. The impact of intraperitoneal glucose and insulin on the liver.
Bargman JM
Perit Dial Int; 1996; 16 Suppl 1():S211-4. PubMed ID: 8728195
[No Abstract] [Full Text] [Related]
16. [Efficacy of the administration of intraperitoneal insulin in diabetic patients undergoing continuous ambulatory peritoneal dialysis].
Coronel Díaz F; Naranjo Gómez P; Serrano Heranz R; Cruceyra Ventín A; Prats Sánchez D
Med Clin (Barc); 1984 May; 82(20):881-4. PubMed ID: 6379332
[No Abstract] [Full Text] [Related]
17. Decreasing insulin requirements in CAPD patients given intraperitoneal insulin.
Grefberg N; Danielson BG; Berne C
J Diabet Complications; 1987; 1(1):16-9. PubMed ID: 2968990
[TBL] [Abstract][Full Text] [Related]
18. Effect of prostaglandin E1 on peritoneal membrane transport in CAPD-treated diabetic patients.
Jaroszynski AJ; Ksiazek A
Perit Dial Int; 2008; 28(5):538-40. PubMed ID: 18708549
[No Abstract] [Full Text] [Related]
19. Marked variation in peritoneal insulin absorption in peritoneal dialysis.
Fine A; Parry D; Ariano R; Dent W
Perit Dial Int; 2000; 20(6):652-5. PubMed ID: 11216554
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal insulin in continuous ambulatory peritoneal dialysis (CAPD): clinical aspects.
Triolo G; Carta Q; Salomone M; Dani F; Passarino G; Boggio Bertinet D; Segoloni GP; Vercellone A
Life Support Syst; 1983; 1 Suppl 1():454-6. PubMed ID: 6400733
[No Abstract] [Full Text] [Related]
[Next] [New Search]
